HomeCompareDTSRF vs MRK

DTSRF vs MRK: Dividend Comparison 2026

DTSRF yields 75.47% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTSRF wins by $1.30M in total portfolio value
10 years
DTSRF
DTSRF
● Live price
75.47%
Share price
$2.65
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.35M
Annual income
$375,142.22
Full DTSRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — DTSRF vs MRK

📍 DTSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTSRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTSRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTSRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTSRF
Annual income on $10K today (after 15% tax)
$6,415.09/yr
After 10yr DRIP, annual income (after tax)
$318,870.89/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, DTSRF beats the other by $310,274.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTSRF + MRK for your $10,000?

DTSRF: 50%MRK: 50%
100% MRK50/50100% DTSRF
Portfolio after 10yr
$705.3K
Annual income
$192,628.00/yr
Blended yield
27.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DTSRF
No analyst data
Altman Z
260.9
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTSRF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTSRFMRK
Forward yield75.47%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1.35M$57.7K
Annual income after 10y$375,142.22$10,113.78
Total dividends collected$1.17M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DTSRF vs MRK ($10,000, DRIP)

YearDTSRF PortfolioDTSRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$18,247$7,547.17$11,213$373.04+$7.0KDTSRF
2$32,395$12,870.51$12,667$512.06+$19.7KDTSRF
3$56,017$21,354.74$14,439$708.14+$41.6KDTSRF
4$94,449$34,510.84$16,640$988.16+$77.8KDTSRF
5$155,442$54,381.15$19,432$1,394.07+$136.0KDTSRF
6$249,967$83,643.80$23,057$1,992.90+$226.9KDTSRF
7$393,173$125,708.24$27,889$2,894.79+$365.3KDTSRF
8$605,486$184,791.09$34,518$4,286.29+$571.0KDTSRF
9$913,831$265,960.98$43,912$6,494.35+$869.9KDTSRF
10$1,352,941$375,142.22$57,714$10,113.78+$1.30MDTSRF

DTSRF vs MRK: Complete Analysis 2026

DTSRFStock

The fund invests directly in ether that are held securely in cold storage while seeking to benefit from staking. Staking refers to the proof-of-stake consensus protocols that ensure transactions are properly recorded on a blockchain. The process allows owners of a cryptocurrency to validate block transactions through validators that verify the accuracy of recorded data. In return, validators are rewarded with digital assets. For the fund, rewards are paid in ether and will depend on the amount of ether staked. Staked ether serve as collateral that are locked in the network but are at risk of loss if validators fail to meet network rules. The fund manager selects and directs experienced sub-custodians as validators for staking activities. In addition, the fund manager has discretion in the amount of staked ether from the portfolio. The ETF does not intend to use derivatives or employ leverage to acquire ether. It may also hold cash, cash equivalents or other money market instruments.

Full DTSRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DTSRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTSRF vs SCHDDTSRF vs JEPIDTSRF vs ODTSRF vs KODTSRF vs MAINDTSRF vs JNJDTSRF vs ABBVDTSRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.